The DOI matches its Crossref record; 404 of the 404 references it cites were found in a registry or an index.
The complexity of p53-mediated metabolic regulation in tumor suppression
Open accessAbstract
Although the classic activities of p53 including induction of cell-cycle arrest, senescence, and apoptosis are well accepted as critical barriers to cancer development, accumulating evidence suggests that loss of these classic activities is not sufficient to abrogate the tumor suppression activity of p53. Numerous studies suggest that metabolic regulation contributes to tumor suppression, but the mechanisms by which it does so are not completely understood. Cancer cells rewire cellular metabolism to meet the energetic and substrate demands of tumor development. It is well established that p53 suppresses glycolysis and promotes mitochondrial oxidative phosphorylation through a number of downstream targets against the Warburg effect. The role of p53-mediated metabolic regulation in tumor suppression is complexed by its function to promote both cell survival and cell death under different physiological settings. Indeed, p53 can regulate both pro-oxidant and antioxidant target genes for complete opposite effects. In this review, we will summarize the roles of p53 in the regulation of glucose, lipid, amino acid, nucleotide, iron metabolism, and ROS production. We will highlight the mechanisms underlying p53-mediated ferroptosis, AKT/mTOR signaling as well as autophagy and discuss the complexity of p53-metabolic regulation in tumor development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“p53 expression modulates multiple metabolic pathways to respond to cellular stress and maintain metabolic homeostasis.125”
From p53: from understanding its structure to advances in therapeutic targeting (2026) · cites this paper as [125]
In the citing paper
“p53 regulates a series of metabolic diseases, including obesity, diabetes, and fatty liver diseases, through its complicated functions.125,261,262”
From p53: from understanding its structure to advances in therapeutic targeting (2026) · cites this paper as [125]
In the citing paper
“p53 also controls a number of “non-classical” pathways (Fig. 2), including metabolic homeostasis, ferroptosis, stem cell differentiation, autophagy, senescence, tumor microenvironment and so on.45–50”
From Targeting p53 pathways: mechanisms, structures, and advances in therapy (2023) · cites this paper as [46]
In the citing paper
“p53 promotes lipolysis leading to tumor suppression.46”
From Targeting p53 pathways: mechanisms, structures, and advances in therapy (2023) · cites this paper as [46]
In the citing paper
“p53 plays a dual role in inhibiting and promoting the tricarboxylic acid cycle and oxidative phosphorylation.46,117,118”
From Targeting p53 pathways: mechanisms, structures, and advances in therapy (2023) · cites this paper as [46]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 401–404 of 404
Genomic alterations during p53-dependent apoptosis induced by γ-irradiation of Molt-4 leukemia cells
Hage‐Sleiman, R., Bahmad, H. F., Kobeissy, H., Dakdouk, Z., Kobeissy, F. H., & Dbaibo, G. S. (2017) · PLoS ONE · doi:10.1371/journal.pone.0190221 · Cited by 16
Huang, J., Du, J., Lin, W., Long, Z., Zhang, N., Huang, X., Xie, Y., Liu, L., & Ma, W. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.06.003 · Cited by 15
Novel Interplay between p53 and HO-1 in Embryonic Stem Cells
Toro, A. R., Anselmino, N., Solari, C., Francia, M. G., Oses, C., Sanchis, P., Bizzotto, J. A., Echegaray, C. V., Petrone, M. V., Levi, V., et al. (2020) · Cells · doi:10.3390/cells10010035 · Cited by 12
Tumour suppressor protein p53 regulates the stress activated bilirubin oxidase cytochrome P450 2A6
Hu, H., Ting, Y., Arpiainen, S., Lang, M. A., Hakkola, J., & Abu-Bakar, A. (2015) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2015.08.021 · Cited by 10
Cited by
Targeting p53 pathways: mechanisms, structures, and advances in therapy
Wang, H., Guo, M., Wei, H., & Chen, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01347-1 · Cited by 1,016
p53 in ferroptosis regulation: The new weapon for the old guardian
Liu, Y., & Gu, W. (2022) · Cell Death & Differentiation · doi:10.1038/s41418-022-00943-y · Cited by 540
Self-citationUnderstanding the complexity of p53 in a new era of tumor suppression
Liu, Y., Su, Z., Tavana, O., & Gu, W. (2024) · Cancer Cell · doi:10.1016/j.ccell.2024.04.009 · Cited by 495
Self-citationCuproptosis: p53-regulated metabolic cell death?
Xiong, C., Ling, H., Hao, Q., & Zhou, X. (2023) · Cell Death & Differentiation · doi:10.1038/s41418-023-01125-0 · Cited by 263
Hu, D., Li, Y., Li, R., Wang, M., Zhou, K., He, C., Wei, Q., & Qian, Z. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.10.015 · Cited by 153
Metadata
- Authors
- Liu, Y., & Gu, W.
- Venue
- Seminars in Cancer Biology
- Publisher
- Elsevier BV
- Published
- 2022-10
- Volume
- 85
- Pages
- 4-32
- ISSN
- 1044-579X (ISSN-L)
- OpenAlex
- W3145198654
- Cited by
- 261
- References
- 404
- FWCI
- 12.80
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.